Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 656

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 656
---
 equity and conversion of shares in accordance with the terms of the Kintara Merger and final exchange ratio:

The elimination of the historical Legacy TuHURA outstanding shares of 226,056,924 (comprised of 71,136,072 shares of common stock, 81,347,397 preferred shares, 13,976,616 preferred dividends to be paid by the issuance of common stock, 4,009,623 shares included within the July 2024 Private Placement, 98,040 shares included within the issuance of common stock to Paulson, and 55,489,176 shares upon the conversion of the Notes).

This also resulted in the reclassification of the value ascribed to each of these instruments and their related Legacy TuHURA financial statement line items into the equity accounts of TuHURA.

The conversion of $24,366,813 of Notes and the elimination of the derivative liability for the conversion option included within the Notes of $2,853,000, all at par value of $0.0001; and the conversion of all the historical Legacy TuHURA outstanding shares aboveat the determined exchange ratio of 0.1789 into 40,441,605 shares which were issued to former Legacy TuHURA upon consummation of the Kintara Merger (after the effect of the 1-35 reverse share split).

The conversion of historical shares of common stock of Kintara into 1,842,920 shares which were issued upon completion of the Kintara Merger as part of the 1-35 reverse share split. Following these conversions and exchange of shares based on the exchange ratio, after completion of the Kintara Merger, TuHURA’s outstanding shares were 42,284,525 which are represented in the pro forma condensed combined financial information for TuHURA Biosciences, Inc. (at par value).

HRepresents adjustments for the estimated preliminary purchase price allocation for the Business Combination between TuHURA Biosciences, Inc. and Kineta; including the resulting elimination of Kineta’s historical equity as a result of the acquisition by TuHURA.

Any adjustments presented on the unaudited pro forma condensed combined balance sheet as of September 30, 2024, which reference this Pro Forma Adjustment Hwhile not being explicitly depicted in the table below, are the result of the net presentation of the estimated preliminary purchase price allocation adjustments in the unaudited pro forma condensed combined balance sheet after accounting for the elimination of Kineta